Clinical Trial Update: Prospective, Observational Study of Biomarkers in Liver Cancer - Identification of Actionable Events

View source ↗

Summary

A prospective observational study of biomarkers in liver cancer (hepatocellular carcinoma) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Hepatocellular Carcinoma | Status: WITHDRAWN